Cleared Special

K062609 - MODIFICATION TO ANGIODYNAMICS PROFILER ...

K062609 is the FDA 510(k) clearance for MODIFICATION TO ANGIODYNAMICS PROFILER ... by AngioDynamics, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 31-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
31d
Days
Class 2
Risk

K062609 is an FDA 510(k) clearance for the MODIFICATION TO ANGIODYNAMICS PROFILER PTA BALLOON CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by AngioDynamics, Inc. (Queensburgy, US). The FDA issued a Cleared decision on October 6, 2006 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all AngioDynamics, Inc. devices

Submission Details

510(k) Number K062609 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 05, 2006
Decision Date October 06, 2006
Days to Decision 31 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 125d · This submission: 31d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 574
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K062609.
ATB ADVANCED PTA DILATATION CATHETER
K063252 · Cook, Inc. · Nov 2006
SELECTSITE C304 DEFLECTABLE CATHETER SYSTEM, MODELS C304-S59, C304-L69, C304-XS59 & C304-XL74
K061416 · Medtronic Vascular · Oct 2006
OCCLUSION BALLOON
K062202 · Boston Scientific Corp · Oct 2006
MODIFICATION TO POLARCATH PERIPHERAL DILATATION SYSTEM
K062594 · Boston Scientific Corporation · Sep 2006
5F SHERPA ACTIVE NX GUIDE CATHETER
K062420 · Medtronic Vascular · Sep 2006
VENTURE WIRE CONTROL CATHETER, MODEL WCC
K061843 · St Jude Medical · Aug 2006